THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Javid Fazili

Concepts (151)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
5
2018
111
0.660
Why?
Hepatitis C, Chronic
4
2018
30
0.610
Why?
Liver Cirrhosis
6
2024
67
0.590
Why?
Esophageal Diseases
1
2017
13
0.560
Why?
Hematoma
1
2017
26
0.560
Why?
Ribavirin
4
2013
9
0.520
Why?
Liver Neoplasms
6
2024
164
0.500
Why?
Intracellular Signaling Peptides and Proteins
3
2024
278
0.440
Why?
Interferon-alpha
3
2013
50
0.420
Why?
Polyethylene Glycols
2
2013
93
0.390
Why?
Pain Clinics
1
2010
2
0.350
Why?
Disease Outbreaks
1
2010
50
0.340
Why?
Cross Infection
1
2010
35
0.340
Why?
Hepatitis C
4
2013
38
0.320
Why?
Prednisone
1
2008
51
0.310
Why?
Carcinoma, Hepatocellular
5
2024
130
0.310
Why?
Hearing Loss
1
2008
37
0.300
Why?
Glucocorticoids
1
2008
114
0.300
Why?
Lamivudine
1
2007
2
0.290
Why?
Reverse Transcriptase Inhibitors
1
2007
8
0.290
Why?
Hepatitis B
1
2007
12
0.290
Why?
MicroRNAs
2
2024
279
0.270
Why?
Middle Aged
11
2024
6907
0.200
Why?
Male
12
2024
13017
0.190
Why?
Gastroenterology
1
2001
14
0.190
Why?
Endoscopy, Gastrointestinal
1
2001
27
0.190
Why?
Gastrointestinal Neoplasms
1
2001
35
0.180
Why?
Fatty Acids, Monounsaturated
2
2013
22
0.180
Why?
Humans
17
2024
27143
0.180
Why?
Aged, 80 and over
3
2017
1939
0.170
Why?
Physician-Patient Relations
1
2001
110
0.170
Why?
beta Catenin
1
2020
62
0.170
Why?
Indoles
2
2013
98
0.170
Why?
Inflammation
1
2024
605
0.170
Why?
Hepatocytes
1
2020
75
0.170
Why?
Biomarkers, Tumor
2
2024
377
0.150
Why?
Hepacivirus
3
2018
46
0.150
Why?
Aged
7
2024
5223
0.150
Why?
Radiography, Thoracic
1
2017
12
0.140
Why?
Rectal Diseases
1
2017
10
0.140
Why?
Choristoma
1
2017
6
0.140
Why?
Gastric Mucosa
1
2017
35
0.140
Why?
Endoscopy
1
2017
53
0.140
Why?
Positron-Emission Tomography
1
2017
98
0.130
Why?
RNAi Therapeutics
1
2015
13
0.130
Why?
Biopsy
2
2010
201
0.130
Why?
Treatment Outcome
5
2018
2286
0.130
Why?
Time Factors
3
2015
1572
0.120
Why?
Gene Knockdown Techniques
1
2015
131
0.120
Why?
Genetic Therapy
1
2015
116
0.120
Why?
Tomography, X-Ray Computed
1
2017
467
0.110
Why?
Recombinant Proteins
3
2013
408
0.110
Why?
Adult
7
2018
7498
0.110
Why?
Evidence-Based Medicine
1
2014
141
0.110
Why?
Viral Load
2
2010
31
0.110
Why?
Carcinogenesis
2
2024
79
0.100
Why?
Retrospective Studies
3
2018
2465
0.100
Why?
Nonprescription Drugs
1
2010
7
0.090
Why?
Medical History Taking
1
2010
18
0.090
Why?
Prescription Drugs
1
2010
15
0.090
Why?
Female
7
2024
14634
0.090
Why?
Hepatitis C Antibodies
1
2010
6
0.090
Why?
Risk Factors
3
2014
2036
0.090
Why?
Chi-Square Distribution
1
2010
144
0.080
Why?
Interferons
1
2010
68
0.080
Why?
RNA, Viral
1
2010
67
0.080
Why?
alpha-Fetoproteins
2
2020
18
0.080
Why?
Dietary Supplements
1
2010
220
0.080
Why?
Age Factors
1
2010
721
0.070
Why?
Risk Assessment
1
2010
594
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2008
58
0.070
Why?
Liver
1
2010
424
0.070
Why?
Acute Disease
1
2007
156
0.070
Why?
Neoplastic Stem Cells
2
2020
139
0.070
Why?
Oklahoma
1
2010
976
0.070
Why?
Tumor Virus Infections
1
2005
14
0.060
Why?
Lymphoma, Non-Hodgkin
1
2005
21
0.060
Why?
Antineoplastic Agents
1
2010
657
0.060
Why?
Killer Cells, Natural
1
2005
61
0.060
Why?
Cell Line, Tumor
2
2020
1269
0.060
Why?
Liver Diseases
1
2024
51
0.060
Why?
Chronic Disease
1
2024
265
0.050
Why?
Young Adult
1
2010
2629
0.050
Why?
Neoplasms
1
2010
767
0.050
Why?
Models, Statistical
1
2002
122
0.050
Why?
Anesthesia Recovery Period
1
2001
2
0.050
Why?
Physician's Role
1
2001
29
0.050
Why?
SOX9 Transcription Factor
1
2020
12
0.040
Why?
Hep G2 Cells
1
2020
28
0.040
Why?
Glycogen Synthase Kinase 3 beta
1
2020
40
0.040
Why?
Heterografts
1
2020
62
0.040
Why?
Spheroids, Cellular
1
2020
53
0.040
Why?
Sustained Virologic Response
1
2018
4
0.040
Why?
Aspartate Aminotransferases
1
2018
20
0.040
Why?
Bilirubin
1
2018
11
0.040
Why?
Alanine Transaminase
1
2018
25
0.040
Why?
Serum Albumin
1
2018
35
0.040
Why?
Rare Diseases
1
2017
7
0.040
Why?
Colonoscopy
1
2017
58
0.030
Why?
Severity of Illness Index
1
2018
447
0.030
Why?
Disease Progression
1
2018
458
0.030
Why?
Databases, Genetic
1
2015
47
0.030
Why?
Diagnosis, Differential
1
2017
368
0.030
Why?
Mice, Inbred C57BL
1
2020
1494
0.030
Why?
RNA Interference
1
2015
135
0.030
Why?
Tumor Burden
1
2015
108
0.030
Why?
Transfection
1
2015
312
0.030
Why?
Mice, Nude
1
2015
312
0.030
Why?
Xenograft Model Antitumor Assays
1
2015
250
0.030
Why?
Up-Regulation
1
2015
240
0.030
Why?
Biomarkers
1
2018
736
0.030
Why?
Hepatorenal Syndrome
1
2014
2
0.030
Why?
Hepatic Encephalopathy
1
2014
5
0.030
Why?
Hypertension, Portal
1
2014
5
0.030
Why?
Esophageal and Gastric Varices
1
2014
7
0.030
Why?
Hepatopulmonary Syndrome
1
2014
3
0.030
Why?
Peritonitis
1
2014
15
0.030
Why?
Ascites
1
2014
19
0.030
Why?
Animals
2
2020
10069
0.030
Why?
Hyponatremia
1
2014
16
0.030
Why?
Bacterial Infections
1
2014
56
0.030
Why?
Phenotype
1
2015
666
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2015
445
0.030
Why?
Drug Therapy, Combination
1
2013
204
0.030
Why?
Cell Proliferation
1
2015
774
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
66
0.020
Why?
Genotype
1
2013
444
0.020
Why?
Transcription Factors
1
2015
514
0.020
Why?
Pharmacology, Clinical
1
2010
4
0.020
Why?
Mice
1
2020
4467
0.020
Why?
Medical Records
1
2010
49
0.020
Why?
Drug Monitoring
1
2010
34
0.020
Why?
Drug Interactions
1
2010
77
0.020
Why?
Self Report
1
2010
116
0.020
Why?
Electronic Health Records
1
2010
60
0.020
Why?
Sex Characteristics
1
2010
163
0.020
Why?
Fibrosis
1
2010
121
0.020
Why?
Signal Transduction
1
2015
1374
0.020
Why?
Liver Function Tests
1
2008
9
0.020
Why?
Administration, Oral
1
2008
166
0.020
Why?
Drug Administration Schedule
1
2008
218
0.020
Why?
Surveys and Questionnaires
1
2010
929
0.020
Why?
Dose-Response Relationship, Drug
1
2008
591
0.020
Why?
Remission Induction
1
2005
50
0.020
Why?
Prospective Studies
1
2008
1223
0.010
Why?
Telangiectasis
1
2002
3
0.010
Why?
Probability
1
2002
75
0.010
Why?
ROC Curve
1
2002
137
0.010
Why?
Platelet Count
1
2002
112
0.010
Why?
Logistic Models
1
2002
398
0.010
Why?
Sex Factors
1
2002
451
0.010
Why?
Fazili's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (151)
Explore
_
Co-Authors (15)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES